Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7222 results

Amgen and Onyx’s MAA for Kyprolis is accepted by EMA

Amgen and Onyx’s MAA for Kyprolis is accepted by EMA

27-02-2015

The European Medicines Agency has accepted the Marketing Authorization Application for Kyprolis (carfilzomib)…

AmgenEuropeKyprolisOncologyOnyx PharmaceuticalsPharmaceuticalRegulation

BIA welcomes UK’s R&D tax credit scheme

BIA welcomes UK’s R&D tax credit scheme

27-02-2015

The UK BioIndustry Association (BIA) is calling for an extended advance assurance scheme in its response…

FinancialPharmaceuticalUKUK BioIndustry AssociationUnited Kingdom

Chiesi found to have breached ABPI Code

Chiesi found to have breached ABPI Code

27-02-2015

Privately-held Italian drugmaker Chiesi Farmaceutici has been publicly reprimanded for providing inaccurate…

Chiesi FarmaceuticiFostairLegalPharmaceuticalRegulationUK

2015 outlook for US and EU pharma; report

2015 outlook for US and EU pharma; report

27-02-2015

According to this Global Pharma US & EU Outlook 2015 report, strategy diversification stays divested…

EuropeManagementMarkets & MarketingMergers & AcquisitionsPatentsPharmaceuticalUSA

2014 a record year for Bayer, with pharma fired up by new products

2014 a record year for Bayer, with pharma fired up by new products

27-02-2015

For German pharma major Bayer, 2014 proved to be a record year, with the company notching up sales of…

BayerFinancialGermanyManagementMarijn DekkersPharmaceutical

Report: Japanese pharma market edging towards $80 Billion by 2020

Report: Japanese pharma market edging towards $80 Billion by 2020

26-02-2015

Japan’s pharmaceutical market value is set to grow at a tepid Compound Annual Growth Rate (CAGR) of…

Bristol-Myers SquibbGlobalDataJapanMarkets & MarketingPharmaceutical

Mundipharma launches monoclonal antibody Remsima in six European markets

26-02-2015

Privately-held UK-based drugmaker Mundipharma International is launching Remsima (infliximab) this month…

Anti-Arthritics/RheumaticsEuropeMarkets & MarketingMundipharmaPharmaceuticalRemsima

Significant drop in pharma applications to EPO shows pace of innovation is dropping

Significant drop in pharma applications to EPO shows pace of innovation is dropping

26-02-2015

The European Patent Office (EPO) has reported an increase in the number of patent filings for the fifth…

BiotechnologyEPOEuropeLegalPharmaceutical

Economist Pharma Summit: BRIC countries must be at forefront of AMR fight, says Jim O'Neill

Economist Pharma Summit: BRIC countries must be at forefront of AMR fight, says Jim O'Neill

26-02-2015

Jim O'Neill, chair of the UK government's review on antimicrobial resistance (AMR), spoke of the need…

AMRAntibiotics and Infectious diseasesPharma SummitPharmaceuticalUK

Ablynx 2014 financial results sees loss decrease thanks to collaborations

Ablynx 2014 financial results sees loss decrease thanks to collaborations

26-02-2015

Belgian drug developer Ablynx has released its 2014 full year results, reporting a decreased loss from…

AblynxBelgiumFinancialMerck & CoPharmaceutical

‘New option’ for diabetes as Sanofi receives FDA approval of Toujeo

‘New option’ for diabetes as Sanofi receives FDA approval of Toujeo

26-02-2015

The US Food and Drug Administration has approved French pharma major Sanofi’s Toujeo (insulin glargine…

DiabetesPharmaceuticalRegulationSanofiToujeoUSA

US FDA approves new antibacterial drug Avycaz

US FDA approves new antibacterial drug Avycaz

26-02-2015

The US Food and Drug Administration has approved antibacterial drug Avycaz (ceftazidime-avibactam) to…

ActavisAntibiotics and Infectious diseasesceftazidime-avibactamForest PharmaceuticalsPharmaceuticalRegulationUSA

Atrial fibrillation market to double by 2020 before steep decline

Atrial fibrillation market to double by 2020 before steep decline

26-02-2015

The global market for atrial fibrillation treatment will more than double in value between 2013 and 2020,…

Cardio-vascularChemistryMarkets & MarketingMedicineOrganic chemistryPharmaceuticalStroke

Sri Lanka must look globally and build exports, report says

Sri Lanka must look globally and build exports, report says

26-02-2015

Sri Lankan pharma companies must aim to penetrate the global market since the internal market is insufficient,…

Bharat BookMarkets & MarketingPharmaceuticalPolitical geographySri Lanka

Sanofi's golden handshake for new chief Olivier Brandicourt under fire

Sanofi's golden handshake for new chief Olivier Brandicourt under fire

25-02-2015

The proposed bonus for Olivier Brandicourt, the new chief executive of Sanofi has drawn criticism from…

Business FinanceFinancialFrancePharmaceuticalPoliticsSanofi

NICE recommends Sovaldi and Olysio for hepatitis C

NICE recommends Sovaldi and Olysio for hepatitis C

25-02-2015

The UK’s National Institute for Health and Care Excellence (NICE) has published final guidance recommending…

Anti-viralsGilead SciencesJanssenOlysioPharmaceuticalRegulationSovaldiUK

Takeda acquires 13 products from Turkish company Neutec

Takeda acquires 13 products from Turkish company Neutec

25-02-2015

Takeda GmbH, the wholly-owned subsidiary of Japanese drugmaker Takeda has signed an agreement to obtain…

Markets & MarketingMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalTurkey

Fujifilm's favipiravir performs well in early-stage Ebola study

Fujifilm's favipiravir performs well in early-stage Ebola study

25-02-2015

A study conducted in Guinea has shown that Fujifilm’s favipiravir halves mortality rates in patients…

Antibiotics and Infectious diseasesfavipiravirFujifilmGuineaPharmaceuticalResearch

Takeda consolidates business in Singapore, opening new office

Takeda consolidates business in Singapore, opening new office

25-02-2015

Japanese drug major Takeda has opened its new office in Biopolis, Singapore. The space will host its…

PharmaceuticalProductionResearchSingaporeTakeda PharmaceuticalsVaccines

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

25-02-2015

The UK’s National Institute for Health and Care Excellence has recommended Inlyta (axitinib), marketed…

DendreonInlytaOncologyPfizerPharmaceuticalPricingProvengeRegulationUKValeant Pharmaceuticals International

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

24-02-2015

US pharma giant Pfizer has announced positive top-line results of a Phase II study of Trumenba (meningococcal…

Antibiotics and Infectious diseasesPfizerPharmaceuticalResearchTrumenbaUSA

Considerable commercial interest in Alzheimer's pipeline despite high rate of attrition, report says

Considerable commercial interest in Alzheimer's pipeline despite high rate of attrition, report says

24-02-2015

Despite a high rate of attrition, there is a considerable level of commercial interest in the Alzheimer’s…

AlzheimerGBI ResearchNeurologicalPharmaceuticalResearch

30% increase in R&D projects for neglected diseases in 2014; report

24-02-2015

Trade group the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has released…

GlobalPharmaceuticalResearchTropical diseases

1 to 25 of 7222 results

COMPANY SPOTLIGHT

Menarini

Back to top